Article
Neonatal detection of Aicardi Goutières Syndrome by increased C26:0 lysophosphatidylcholine and interferon signature on newborn screening blood spots.
Molecular genetics and metabolism - 1 Nov 2017
Armangue Thais, Orsini Joseph J, Takanohashi Asako, Gavazzi Francesco, Conant Alex, Ulrick Nicole, Morrissey Mark A, Nahhas Norah, Helman Guy, Gordish-Dressman Heather, Orcesi Simona, Tonduti Davide, Stutterd Chloe, van Haren Keith, Toro Camilo, Iglesias Alejandro D, van der Knaap Marjo S, Goldbach Mansky Raphaela, Moser Anne B, Jones Richard O, Vanderver Adeline
Abstract excerpt
BACKGROUND: Aicardi Goutières Syndrome (AGS) is a heritable interferonopathy associated with systemic autoinflammation causing interferon (IFN) elevation, central nervous system calcifications, leukodystrophy and severe neurologic sequelae. An infant with TREX1 mutations was recently found to have abnormal C26:0 lysophosphatidylcholine (C26:0 Lyso-PC) in a newborn screening platform for X-linked...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
